Iladatuzumab, CAS 1906205-76-2

Product Description: Iladatuzumab (MCDS0593A) is a humanized IgG1 anti-human CD79B monoclonal antibody. Iladatuzumab can be used to synthesize antibody-drug conjugates (ADC) Iladatuzumab vedotin (DCDS0780A; HY-P99657), which has the potential for B-cell non-Hodgkin lymphoma (B-NHL) research[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Alex F Herrera, et al. Anti-CD79B Antibody-Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study. Clin Cancer Res. 2022 Apr 1;28(7):1294-1301./[2]Louise Conilh, et al. Payload diversification: a key step in the development of antibody-drug conjugates. J Hematol Oncol. 2023 Jan 17;16(1):3.

CAS Number: 1906205-76-2

Molecular Weight: N/A

Compound Purity: 96.97

Research Area: Cancer

Solubility: H2O

Target: ADC Antibody

• SKU: MEXHY-P99656-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99656-10
• Package Unit: 10 mg
• Quantity Unit: STK
• Conjugate: Unconjugated